Sponsor Pipeline

ReBio Pharma Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-05 NCT07747935 Study of Neoadjuvant RBP-01 In Patients With Primary Uveal Melanoma Phase 1/2 Not Yet Recruiting
Active Trials by Phase
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07747935 Study of Neoadjuvant RBP-01 In Patients With Primary Uveal Melanoma Uveal Melanoma Not Yet Recruiting
Disease Areas
Melanoma (1)
Get alerts when ReBio Pharma's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free